Leaflet RABEPRAZOL TEVA 20mg gastro-resistant tablets

Indicated for: peptic ulcer; gastroesophageal reflux

Route of administration: oral

Substance: rabeprazole (proton pump inhibitor)

ATC: A02BC04 (Alimentary tract and metabolism | Drugs for peptic ulcer and gastro-oesophageal reflux disease (gord) | Proton pump inhibitors)

Rabeprazole is a proton pump inhibitor used for the treatment of gastroesophageal reflux disease (GERD), gastric ulcers, and other conditions associated with excessive gastric acid secretion. It works by reducing gastric acid production, alleviating symptoms, and promoting healing of the gastric mucosa.

The medication is taken orally, as directed by a doctor, usually once daily before a meal. It is important for patients to follow the treatment regimen and inform the doctor about any other medications being used.

Patients should be aware of potential side effects, such as headaches, nausea, or diarrhea. It is important to inform the doctor of any unusual symptoms.

Common side effects include headaches, nausea, and diarrhea. In rare cases, severe reactions such as allergic reactions or hypomagnesemia may occur. Patients should be informed of these risks before use.

General data about RABEPRAZOL TEVA 20mg

  • Substance: rabeprazole
  • Date of latest medicines list: 01-07-2013
  • Product code: W57276002
  • Concentration: 20mg
  • Pharmaceutical form: gastro-resistant tablets
  • Quantity: 7
  • Product type: Generic medicine
  • Prescription status: P-6L - Medicines dispensed with a medical prescription that is not retained by the pharmacy and may be renewed; the prescription may be used for 6 months from the date of issue.

Pharmaceutical forms available for rabeprazole

Concentrations available for rabeprazole

  • 10mg
  • 20mg